| Clinical applications of antimicrobial peptides (AMPs): where do we stand now? M Divyashree, MK Mani, D Reddy, R Kumavath, P Ghosh, V Azevedo, ... Protein and peptide letters 27 (2), 120-134, 2020 | 128 | 2020 |
| Lanatoside C induces G2/M cell cycle arrest and suppresses cancer cell growth by attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR signaling pathways D Reddy, R Kumavath, P Ghosh, D Barh Biomolecules 9 (12), 792, 2019 | 102 | 2019 |
| Anticancer and antiviral properties of cardiac glycosides: a review to explore the mechanism of actions D Reddy, R Kumavath, D Barh, V Azevedo, P Ghosh Molecules 25 (16), 3596, 2020 | 74 | 2020 |
| Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers D Reddy, R Kumavath, TZ Tan, DR Ampasala, AP Kumar Life sciences 241, 117147, 2020 | 60 | 2020 |
| Anti-quorum sensing and anti-biofilm activity of 5-hydroxymethylfurfural against Pseudomonas aeruginosa PAO1: Insights from in vitro, in vivo and in silico studies J Rajkumari, S Borkotoky, D Reddy, SK Mohanty, R Kumavath, A Murali, ... Microbiological research 226, 19-26, 2019 | 56 | 2019 |
| Strophanthidin attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-catenin signaling pathways in human cancers D Reddy, P Ghosh, R Kumavath Frontiers in oncology 9, 1469, 2020 | 49 | 2020 |
| Mosloflavone attenuates the quorum sensing controlled virulence phenotypes and biofilm formation in Pseudomonas aeruginosa PAO1: In vitro, in vivo and in silico approach S Hnamte, P Parasuraman, S Ranganathan, DR Ampasala, D Reddy, ... Microbial pathogenesis 131, 128-134, 2019 | 47 | 2019 |
| Inhibition of microbial quorum sensing mediated virulence factors by Pestalotiopsis sydowiana P Parasuraman, B Devadatha, VV Sarma, S Ranganathan, DR Ampasala, ... Journal of Microbiology and Biotechnology 30 (4), 571, 2020 | 29 | 2020 |
| Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions DSR Bandi, S Sarvesh, B Farran, GP Nagaraju, BF El-Rayes Cytokine & Growth Factor Reviews 71, 26-39, 2023 | 10 | 2023 |
| UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress R Dutta, P Guruvaiah, KK Reddi, S Bugide, DS Reddy Bandi, ... NAR cancer 4 (4), zcac035, 2022 | 9 | 2022 |
| LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition P Malvi, DS Reddy, R Kumar, S Chava, S Burela, K Parajuli, X Zhang, ... Oncogene 42 (18), 1478-1491, 2023 | 7 | 2023 |
| A novel Pan-RAS inhibitor with a unique mechanism of action blocks tumor growth in mouse models of GI cancer JB Foote, TE Mattox, AB Keeton, X Chen, FT Smith, KL Berry, T Holmes, ... bioRxiv, 2023.05. 17.541233, 2023 | 5 | 2023 |
| ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma DS Reddy Bandi, GP Nagaraju, S Sarvesh, JL Carstens, JB Foote, ... bioRxiv, 2024.10. 04.616725, 2024 | 1 | 2024 |
| A potent and selective pan-RAS inhibitor, ADT-1004, targeting complex KRAS mutations for pancreatic cancer. GA Piazza, RDS Bandi, PN Ganji, JB Foote, AB Keeton, TE Mattox, ... Journal of Clinical Oncology 42 (16_suppl), e15085-e15085, 2024 | 1 | 2024 |
| Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine GP Nagaraju, MS Saddala, JB Foote, AM Khaliq, A Masood, Y Golivi, ... Cell Reports Medicine, 2024 | | 2024 |
| A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer JB Foote, TE Mattox, AB Keeton, X Chen, FT Smith, K Berry, TW Holmes, ... Cancer Research, 2024 | | 2024 |
| 127 (PB115): Survival benefit and tumor regression with a dual RAS/β-catenin inhibitor, ADT-030, in murine models of pancreatic and lung cancer DSR Bandi, GP Nagaraju, JB Foote, A Keeton, X Chen, KL Berry, ... European Journal of Cancer 211, 114650, 2024 | | 2024 |
| 133 (PB121): A novel pan-RAS inhibitor (ADT-1004) with superior efficacy over mutation-specific KRAS inhibitors in mouse models of pancreatic cancer DSR Bandi, GP Nagaraju, JB Foote, A Keeton, X Chen, KL Berry, ... European Journal of Cancer 211, 114656, 2024 | | 2024 |
| Abstract C027: Efficacy advantages of a novel pan-RAS inhibitor, ADT-1004, over mutant-specific KRAS inhibitors for suppressing pancreatic tumor growth in murine models DS Reddy Bandi, GP Nagaraju, JB Foote, AB Keeton, X Chen, KL Berry, ... Cancer Research 84 (17_Supplement_2), C027-C027, 2024 | | 2024 |
| Abstract C025: A novel pan-RAS/β-catenin inhibitor, ADT-030, produces tumor regression in PDX models of pancreatic cancer DS Reddy Bandi, GP Nagaraju, JB Foote, AB Keeton, X Chen, KL Berry, ... Cancer Research 84 (17_Supplement_2), C025-C025, 2024 | | 2024 |
Preetam GhoshProfessor of Computer Science, Virginia Commonwealth University在 vcu.edu 的电子邮件经过验证
